Identity
- Security key
- 15271
- Ticker
- FEMY
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-06-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- FEMY
Detail
Enriched 2026-08-14 20:47
- Market cap
- $7,095,904.9
- Shares outstanding (class)
- 3,019,534
- Shares outstanding (weighted)
- 3,019,534
- SIC
- 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Employees
- 54
- Location
- SUWANEE, GA
- Homepage
- https://www.femasys.com
- Description
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.